MedTrace Logo

A Taiwan-Adapted Self-Management Program for Adults With Irritable Bowel Syndrome

NCT07693907 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-07-15

No results posted yet for this study

Summary

This pilot randomized controlled trial will evaluate the feasibility, acceptability, and preliminary effects of a Taiwanese version of a comprehensive self-management program for adults with irritable bowel syndrome. Participants will be randomized to the self-management program or usual care. Outcomes will be assessed at baseline, immediately after the intervention, and three months after the intervention.

Conditions

  • Irritable Bowel Syndrome

Interventions

BEHAVIORAL

Comprehensive Self-Management Program

Participants assigned to the intervention group will receive an 8-session comprehensive self-management program over approximately 8 weeks. The program includes irritable bowel syndrome education, symptom monitoring, relaxation practice, cognitive strategies, dietary self-management, sleep-related content, problem solving, and daily-life symptom management.

OTHER

Usual Care

Participants assigned to the usual care group will continue to receive usual clinical care and complete scheduled study assessments.

Sponsors & Collaborators

  • Tri-Service General Hospital (TSGH)

    collaborator OTHER

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • National Defense Medical Center, Taiwan

    lead OTHER

Principal Investigators

  • Pei-Lin Yang, PhD · School of Nursing National Defense Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2027-12-31
Completion
2028-07-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07693907 on ClinicalTrials.gov